Navinci Diagnostics
The company develops and provides in situ proximity ligation assay-based solutions for spatial proteomics. Its proprietary Naveni technology enables the precise detection, visualization, and quantification of protein-protein interactions and post-translational modifications in cultured cells and tissue samples. These tools are primarily used by life science researchers and pathologists to study immune cell dynamics and tumor microenvironments.
Visit websiteUppsala, Sweden
Healthtech
Biotechnology
Life Sciences
Diagnostics
Funding summary
- Total raised
- €8.5M
- Funding rounds
- 1
Investors in Navinci Diagnostics
Investors on record for Navinci Diagnostics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Navinci Diagnostics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors